NASDAQ:RPID • US75340L1044
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for RAPID MICRO BIOSYSTEMS INC-A (RPID).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-07-28 | Lake Street | Initiate | Buy |
| 2025-02-12 | Keybanc | Initiate | Overweight |
| 2023-03-07 | Morgan Stanley | Reiterate | Equal-Weight |
| 2022-08-16 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2022-05-11 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-03-07 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-02-15 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-11-15 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-08-09 | Stifel | Initiate | Buy |
| 2021-08-09 | Cowen & Co. | Initiate | Outperform |
| 2021-08-09 | JP Morgan | Initiate | Overweight |
| 2021-08-09 | Morgan Stanley | Initiate | Equal-Weight |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 17.13M -26.26% | 22.519M 31.46% | 28.051M 24.57% | 33.635M 19.91% | 40.01M 18.95% | 47.379M 18.42% | 63.546M 34.12% | 76.194M 19.90% | 92.616M 21.55% | |
| EBITDA YoY % growth | -60.38M -32.12% | -53.458M 11.46% | -46.557M 12.91% | -42.942M 7.76% | -34.884M 18.76% | -26.214M 24.85% | N/A | N/A | N/A | |
| EBIT YoY % growth | -63.22M -33.86% | -56.563M 10.53% | -49.919M 11.75% | -45.934M 7.98% | -41.387M 9.90% | -28.866M 30.25% | -32.13M -11.31% | -27.846M 13.33% | -22.236M 20.15% | |
| Operating Margin | -369.06% | -251.18% | -177.96% | -136.57% | -103.44% | -60.93% | -50.56% | -36.55% | -24.01% | |
| EPS YoY % growth | -1.43 28.47% | -1.22 14.69% | -1.08 11.48% | -1.01 0.93% | -0.88 17.78% | -0.72 18.26% | -0.59 17.73% | -0.48 18.97% | -0.33 31.91% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.24 8.46% | -0.20 24.44% | -0.21 17.62% | -0.20 27.14% |
| Revenue Q2Q % growth | 7.786M 8.06% | 9.588M 32.03% | 10.302M 31.44% | 11.73M 3.97% |
| EBITDA Q2Q % growth | -8.568M 20.77% | N/A | N/A | N/A |
| EBIT Q2Q % growth | -10.71M 8.16% | -9.996M 17.71% | -10.2M 10.31% | -9.894M 5.52% |
All data in USD
10 analysts have analysed RPID and the average price target is 8.16 USD. This implies a price increase of 226.4% is expected in the next year compared to the current price of 2.5.
RAPID MICRO BIOSYSTEMS INC-A (RPID) will report earnings on 2026-05-07.
The consensus EPS estimate for the next earnings of RAPID MICRO BIOSYSTEMS INC-A (RPID) is -0.24 USD and the consensus revenue estimate is 7.79M USD.
The expected long term growth rate for RAPID MICRO BIOSYSTEMS INC-A (RPID) is 23.62%.